Smith J Bryan, Theakston R David G, Coelho Ana Lucia J, Barja-Fidalgo Christina, Calvete Juan J, Marcinkiewicz Cezary
Department of Pharmacology, Sol Sherry Thrombosis Research Center, Temple University, School of Medicine, Philadelphia, PA 19140, USA.
FEBS Lett. 2002 Feb 13;512(1-3):111-5. doi: 10.1016/s0014-5793(02)02233-0.
Ocellatusin is a new RGD-containing short monomeric disintegrin. It is a better inhibitor of alpha(5)beta(1) integrin and a more potent inducer of the expression of a ligand-induced binding site epitope on beta(1) integrin subunit than echistatin. In further contrast to echistatin, ocellatusin has a direct chemotactic stimulus on human neutrophils in vitro. The distinct effects of these two close evolutionarily related disintegrins might be explained by the presence of methionine-22 and histidine-29 in the RGD loop of ocellatusin, which are arginine and aspartic acid, respectively, in echistatin. These mutations may modulate the conformation and/or recognition properties of the integrin-binding loop of ocellatusin.
矛头蝮素是一种新的含RGD的短单体解整合素。它是α(5)β(1)整合素的更好抑制剂,并且比echistatin更有效地诱导β(1)整合素亚基上配体诱导结合位点表位的表达。与echistatin进一步不同的是,矛头蝮素在体外对人中性粒细胞有直接趋化刺激作用。这两种在进化上密切相关的解整合素的不同作用可能是由于矛头蝮素的RGD环中存在甲硫氨酸-22和组氨酸-29,而在echistatin中分别为精氨酸和天冬氨酸。这些突变可能会调节矛头蝮素整合素结合环的构象和/或识别特性。